App-Quantinova.ai

Initial Phase 3 Results Of The First (Frontline Investigation Of Lenalidomide + Dexamethasone Versus Standard Thalidomide) Trial (MM-020/IFM 07 01) In Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Ineligible For Stem Cell Transplantation (SCT)

Thierry Facon - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Dexamethasone

Protective Mechanisms Of Inter-Alpha Inhibitor Protein On Extracellular Histone Toxicity

Hala Chaaban - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Chondroitin sulfate

Identification Of a Novel Small Molecule Inhibitor Of ASK1 As a Potent Anti-Platelet Agent

Meghna Ulhas Naik - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Epinephrine

Pikfyve Deletion In Platelets Causes Aberrant Platelet Lysosomal Storage Associated With Inappropriate Inflammatory Response

Sang H Min - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Phosphatidylinositol

Blocking Protein S To Treat Hemophilia A

Luca Bologna - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

FVIII

Adamts-18 Is a Novel Candidate Gene Of Vascular Development That Is Related To Aggravated Thrombosis: Evidence From a Adamts-18 Knock Out Mice

Wei Zhang - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Epinephrine

GPIb? As a Selective Bidirectional Modulator Of ?-Thrombin Prothrombotic Functions Influencing Fibrin Deposition and PAR-Dependent Platelet Activation

Alessandro Zarpellon - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

Increased Platelet Thrombus Formation Under Flow Condition In Myeloproliferative Neoplasms (MPN)

Alfonso Vignoli - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Phosphatidylserine

Antiphospholipid Antibodies Stimulate Release Of Endothelial Cell Microparticles Enriched In IL-1?

Meifang Wu - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Interleukin

Genetic and Pharmacologic Targeting Of Alox5 Attenuates JAK2V617F Induced PV In Mice

Yaoyu Chen - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

L-Tyrosine

Biomarkers Of Complement and Endothelial Activation, Inflammation, Thrombosis and Renal Injury In Patients (pts) With aHUS Treated With Eculizumab (ECU)

Roxanne Cofiell - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

Thrombomodulin alfa

The Spectrum Of Cold Agglutinin Disease At The Era Of Rituximab: A Retrospective Study On 48 Patients

Mathilde Lamarque - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Oraprine

Venous Thromboembolism Incidence In The Cooperative Study Of Sickle Cell Disease: The Untold Story

Rakhi P. Naik - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Heme Potently Stimulates Tissue Factor Expression By Peripheral Blood Monocytes: A Novel Mechanism For Thrombosis In Intravascular Hemolytic Diseases

Teena Rehani - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

andrographolide

Venous Thromboembolism In Pregnant Women With Sickle Cell Disease

Craig D. Seaman - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

A North American Experience Of Hemoglobin SC Disease, Its Complications, and Management

Veronique Naessens - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Hydroxyurea

Effect Of Blood Transfusion Therapy On Coagulation Activation In Sickle Cell Disease Patients With High TCD Velocity

Hyacinth Idu Hyacinth - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Evithrom

Microparticles As Biomarkers Of Osteonecrosis Of The Hip In Sickle Cell Disease

Anne M Marsh - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Venous thrombosis

N/A

Hydroxyurea Therapy Reduces The Hypercoagulability State In a Sickle Cell Mouse Model

Marina Pereira Colella - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Hydroxyurea

Prophylactic Dose Low Molecular Weight Heparin (dalteparin) For Treatment Of Vaso-Occlusive Pain Crisis In Patients With Sickle Cell Disease

Nirmish Shah - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

dalteparin Subcutaneous

Filters

7277 Abstracts